تعديل

lundi 4 janvier 2016

AXIM bags pot discount for gum to treat multiple sclerosis

(Reuters) - AXIM Biotechnologies Inc, a small, Manhattan-based company with ties to the Netherlands, says it has a trump card in its quest to develop a cannabis-based chewing gum to ease the symptoms of multiple sclerosis.


http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro

Aucun commentaire:

Enregistrer un commentaire